These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 19040664)

  • 21. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods for the classification of leprosy for treatment purposes.
    Pardillo FE; Fajardo TT; Abalos RM; Scollard D; Gelber RH
    Clin Infect Dis; 2007 Apr; 44(8):1096-9. PubMed ID: 17366457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy.
    Schuring RP; Moet FJ; Pahan D; Richardus JH; Oskam L
    Lepr Rev; 2006 Dec; 77(4):343-55. PubMed ID: 17343221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.
    Parkash O; Kumar A; Nigam A; Franken KL; Ottenhoff TH
    Scand J Immunol; 2006 Oct; 64(4):450-5. PubMed ID: 16970689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for developing leprosy--a population-based cohort study in Indonesia.
    Bakker MI; Hatta M; Kwenang A; Van Mosseveld P; Faber WR; Klatser PR; Oskam L
    Lepr Rev; 2006 Mar; 77(1):48-61. PubMed ID: 16715690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of ML Flow test in leprosy classification.
    Grossi MA; Leboeuf MA; Andrade AR; Lyon S; Antunes CM; Bührer-Sékula S
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():34-8. PubMed ID: 19618073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on performance of two serological assays for diagnosis of leprosy patients.
    Parkash O; Chaturvedi V; Girdhar BK; Sengupta U
    Lepr Rev; 1995 Mar; 66(1):26-30. PubMed ID: 7731338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipstick assay to identify leprosy patients who have an increased risk of relapse.
    Bührer-Sékula S; Cunha MG; Foss NT; Oskam L; Faber WR; Klatser PR
    Trop Med Int Health; 2001 Apr; 6(4):317-23. PubMed ID: 11348523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
    Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
    Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of multibacillary leprosy patients using a phenolic glycolipid-I-based ELISA. Do increasing ELISA-values after discontinuation of treatment indicate relapse?
    Chin-a-Lien RA; Faber WR; van Rens MM; Leiker DL; Naafs B; Klatser PR
    Lepr Rev; 1992 Mar; 63(1):21-7. PubMed ID: 1569812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-quantitative detection of Mycobacterium leprae antigens in skin scrapings: suitability as a laboratory aid for field diagnosis of leprosy.
    Chaturvedi V; Girdhar BK; Sengupta U; Sinha S
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):699-706. PubMed ID: 17445850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LightCycler real-time PCR for rapid detection and quantitation of Mycobacterium leprae in skin specimens.
    Rudeeaneksin J; Srisungngam S; Sawanpanyalert P; Sittiwakin T; Likanonsakul S; Pasadorn S; Palittapongarnpim P; Brennan PJ; Phetsuksiri B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):263-70. PubMed ID: 18783434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of modified lepro-agglutination as screening test for leprosy.
    Thawani G; Mukherjee A; Bhatia VN
    Indian J Lepr; 1994; 66(3):315-20. PubMed ID: 7861046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy.
    Bang PD; Suzuki K; Phuong le T; Chu TM; Ishii N; Khang TH
    J Dermatol; 2009 May; 36(5):269-76. PubMed ID: 19382997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative characteristics of antigenic profile of M. leprae and M. lufu.
    Salamatina OS; Dyachina MN; Juscenko AA; Parshin MP; Chernoyusova LN
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):39-43. PubMed ID: 11480317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.